Kiran Patel’s Post

Alan Held's battle with stage-four prostate cancer saw a promising turn through theranostics in Germany, after traditional treatments showed limited success. This innovative approach, combining diagnostics and therapy, led to significant reductions in his cancer. Alan's journey, supported by his family and the expertise of Dr. Frankis Almaguel, is a testament to the potential of precision medicine. Notably, theranostics for prostate cancer care has now received FDA approval in the US, with Privado Health emerging as a leader in this field. For more details, visit the full story- https://lnkd.in/d2B-C_MJ #CancerWarrior #TheranosticsTriumph #ProstateCancerAwareness #HopeInHealing #PrecisionMedicine #InnovateToCure #FDAApprovedTherapy #SurvivorStories #PrivadoHealth #FightCancerWithInnovation #HealthInnovationLeaders #CuttingEdgeCure #EmpoweredPatientJourney #WholeHealth #BeatCancer

Hepatocellular carcinoma (HCC) accounts for about 85%-90% of all primary #livercancers, the sixth most-commonly diagnosed cancer worldwide and third most common cause of cancer death, with little improvement in survival rates over the past ten years.   The EASL Liver Cancer Summit 2024 brings together clinicians, researchers, nurses, patient advocates, and industry professionals this week in Rotterdam, the Netherlands, to focus on primary liver tumors such as HCC and biliary tract cancer (BTC). We look forward to joining with experts and thought leaders to address the latest challenges and successes in #livercancer care.   Explore the agenda for the #LiverCancerSummit: https://lnkd.in/eMYEicQj

This week, Dr. Michael J. Pishvaian, Johns Hopkins Medicine and Principal Investigator of the Phase III TIGeR-PaC clinical trial, will present at the Global Summit on Gastrointestinal Malignancies in Bermuda. The presentation, "Increasing Local Gemcitabine Delivery Using TAMP in the Chemotherapy Advances in Pancreatic Cancer," reviews the clinical limitations of the current standard of care for patients diagnosed with locally advanced pancreatic cancer (LAPC). Dr. Pishvaian will also highlight Trans-Arterial Micro-Perfusion (TAMP™) designed to ensure precise delivery for targeted treatment of cancer, and its potential for increased safety, tolerance, and improved efficacy. https://bit.ly/3Q3ZmSd #DAVABermudaGI #LAPC #PancreaticCancer

Roche 's Alecensa Achieves Breakthrough Phase III Results in ALK-Positive Early-Stage Lung Cancer: Promising Disease-Free Survival and Potential to Transform Early-Stage Treatment https://lnkd.in/eZh2f-Vs Make sure to follow the Practical Patient Care page and remember to subscribe for our weekly newsletter to stay updated on #diagnostics , #woundcare, #infectionprevention , and #criticalcare  topics. #followus

Together with our partner Jazz Pharmaceuticals, we are proud to share updated data from a Phase 2a trial of an investigational HER2-targeted, bispecific antibody in patients with HER2-positive (HER2+)/HR-positive (HR+) metastatic #breastcancer, presented today during #SABCS23. Metastatic breast cancer is an aggressive and devastating disease, and these late-breaking data further reinforce the potential to address some of the greatest unmet needs in #cancer with #HER2 expression.

3 things we can do to improve the physical and emotional recovery of Head and Neck Cancer patients - Julie McCrossin AM Head and Neck Cancer Australia #RadiationTherapy #Cancer #OncoDaily #Oncology #CancerPrevention

Important information on cancer treatment #sideeffects for #metastaticbreastcancer patients. From American Society of Clinical Oncology (ASCO) #patientadvocate #nonprofitleadership #breastcancer #breastreconstruction #shareddecisionmaking supporting #sdg3

Research shows that emergency departments play a crucial role in the initial diagnosis of lung cancer and subsequent treatment coordination. This showcases the importance of the earliest steps in lung cancer treatment - namely, encouraging patients to attend screening, the lung screening process itself, and how subsequent treatment is personalised based on screening results and patient conditions. #lungcancer #lungscreening #lunghealth